[HTML][HTML] Psychedelics as a novel approach to treating autoimmune conditions

C Thompson, A Szabo - Immunology letters, 2020 - Elsevier
With a rise in the incidence of autoimmune diseases (AiD), health care providers continue to
seek out more efficacious treatment approaches for the AiD patient population. Classic …

[HTML][HTML] IUPHAR review: Navigating the role of preclinical models in pain research

SA Karimi, FT Zahra, LJ Martin - Pharmacological Research, 2024 - Elsevier
Chronic pain is a complex and challenging medical condition that affects millions of people
worldwide. Understanding the underlying mechanisms of chronic pain is a key goal of …

[HTML][HTML] Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine

J Zhou, G Peng, W Liang, Z Chen, Y Liu… - Frontiers in …, 2023 - frontiersin.org
Ketamine is a racemic mixture of equal amounts of R-ketamine and S-ketamine and is well
known to anesthesiologists for its unique dissociative anesthetic properties. The …

Peripherally acting opioid analgesics and peripherally-induced analgesia

V Martínez, R Abalo - Behavioural pharmacology, 2020 - journals.lww.com
The management of pain, particularly chronic pain, is still an area of medical need. In this
context, opioids remain a gold standard for the treatment of pain. However, significant side …

[HTML][HTML] S-ketamine pretreatment Alleviates anxiety-like behaviors and mechanical allodynia and blocks the pro-inflammatory response in striatum and periaqueductal …

S Yang, K Xu, X Xu, J Zhu, Y Jin, Q Liu, R Xu… - Frontiers in Behavioral …, 2022 - frontiersin.org
This study aims to explore the regulatory effect of S-ketamine on the mechanical allodynia,
anxiety-like behaviors and microglia activation in adult male rats exposed to an animal …

[HTML][HTML] The endogenous opioid system in the medial prefrontal cortex mediates ketamine's antidepressant-like actions

C Jiang, RJ DiLeone, C Pittenger, RS Duman - Translational Psychiatry, 2024 - nature.com
Recent studies have implicated the endogenous opioid system in the antidepressant actions
of ketamine, but the underlying mechanisms remain unclear. We used a combination of …

[HTML][HTML] Application of Ketamine in Pain Management and the Underlying Mechanism

X Ma, J Yan, H Jiang - Pain Research and Management, 2023 - hindawi.com
Since ketamine was approved by the FDA as an intravenous anesthetic, it has been in
clinical use for more than 50 years. Apart from its anesthetic effects, ketamine is one of the …

Role of opioidergic system in regulating depression pathophysiology

G Anderson, M Maes - Current Pharmaceutical Design, 2020 - ingentaconnect.com
Background: There is a clear clinical need for a better understanding of the biological
underpinnings of major depressive disorder (MDD), allowing for the development of a …

The antipsychotic aripiprazole induces peripheral antinociceptive effects through PI3Kγ/NO/cGMP/KATP pathway activation

RCM Ferreira, DL de Almeida… - … Journal of Pain, 2022 - Wiley Online Library
Bckground Aripiprazole is an antipsychotic drug used to treat schizophrenia and bipolar
disorder. Recently, its peripheral analgesic component was evaluated, however, the …

Endogenous opioid and cannabinoid systems modulate the muscle pain: A pharmacological study into the peripheral site

WA Gonçalves, RCM Ferreira, BM Rezende… - European Journal of …, 2021 - Elsevier
The participation of the peripheral opioid and cannabinoid endogenous systems in
modulating muscle pain and inflammation has not been fully explored. Thus, the aim of this …